SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

Shanghai Haohai Biological Technology Co., Ltd.

6826

CNE100001W69

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:09:09 2024-04-25 am EDT			5-day change	1st Jan Change
40.15 ^HKD	+0.63%		+3.21%	-0.37%

Mar. 11	Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%	MT
Mar. 08	Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023	CI

Shanghai Haohai Biological Technology Co., Ltd. Proposes Ordinary Final Dividend for the Year Ended December 31, 2021

March 28, 2022 at 07:27 pm EDT

Shanghai Haohai Biological Technology Co., Ltd. proposed ordinary final dividend for the year ended December 31, 2021, of RMB 0.7 per share.

Latest news about Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%	Mar. 11	MT
Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023	Mar. 08	CI
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Shanghai Haohai Biological Forecasts Up to 138% Boost in 2023 Profit	Jan. 29	MT
Shanghai Haohai Biological Technology Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2023	Jan. 29	CI
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.	Jan. 02	CI
Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee	Dec. 01	CI
Haohai Biological Technology's Q3 Profit Rises 34%; Hong Kong Shares Jump 5%	23-10-26	MT
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.	23-10-09	CI
Shanghai Haohai Biological Technology Co., Ltd. commences an Equity Buyback Plan for 1,538,461 shares, representing 0.9% for CNY 200 million, under the auhtorization approved on September 15, 2023.	23-09-26	CI
Shanghai Haohai Biological Technology to See Rise in January-September Profit	23-09-25	MT
Shanghai Haohai Biological Technology Co., Ltd. Provides Unaudited Consolidated Financial Guidance for the Nine Months Ended 30 September 2023	23-09-25	CI
Shanghai Haohai Biological Technology's Profit Surges 188.9% in H1; Shares Up 3%	23-08-18	MT
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Shanghai Haohai Biological Technology Co., Ltd. authorizes a Buyback Plan.	23-08-16	CI
Shanghai Haohai Biological to Buy Remaining Stake in Medical Aesthetics, Cosmetology Business	23-08-01	MT
Shanghai Haohai Biological Technology Co., Ltd. entered into the equity transfer agreement to acquire 36.3636% stake in OHMK Medical Technology Co., Ltd. from Tianjin Huacan Enterprise Management Consulting Partnership, Shanghai Ermei Enterprise Management Consulting Partnership, Yuan Yibing, Lian Songyong and Chen Guangfei for approximately CNY 150 million.	23-07-31	CI
Shanghai Haohai Biological Technology’s H1 Profit to See Up to 210% Boost	23-07-21	MT
Shanghai Haohai Biological Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023	23-07-21	CI
Shanghai Haohai Biological Technology Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on August 11, 2023	23-06-12	CI
Shanghai Haohai Biological Technology Co., Ltd. Announces Final Cash Dividend for the Year Ended December 31, 2022	23-05-10	CI
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai Haohai Biological Technology Co., Ltd. Announces Ordinary Final Dividend for the Year Ended December 31, 2022	23-03-24	CI
Shanghai Haohai Biological Technology's 2022 Profit Halves	23-02-27	MT

Chart Shanghai Haohai Biological Technology Co., Ltd.

Duration

Period

Chart Shanghai Haohai Biological Technology Co., Ltd.

More charts

Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Shanghai Haohai Biological Technology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

37.16 CNY

Average target price

65.08 CNY

Spread / Average Target

+75.14%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.	-0.37%	1.92B
ABBOTT LABORATORIES	-2.92%	185B
MEDTRONIC PLC	-3.80%	107B
BECTON, DICKINSON AND COMPANY	-5.48%	67.55B
DEXCOM, INC.	+11.22%	54.6B
CENCORA, INC.	+16.74%	47.42B
HOYA CORPORATION	+3.86%	42.24B
WEST PHARMACEUTICAL SERVICES, INC.	+4.56%	28.24B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.64%	26.42B
TERUMO CORPORATION	+12.40%	25.66B

Other Medical Equipment, Supplies & Distribution